Nahdi Medical Co. intrinsic value and dividend analysis using DCF, P/B, PEG and PSG models. Includes dividend yield, payout ratio, and dividend sustainability assessment. Sector: Consumer Staples Distribution & Retail. Listed on Saudi Exchange Tadawul.
Nahdi Medical Company operates pharmacy and healthcare retail chains in Saudi Arabia and the UAE, selling pharmaceuticals, cosmetics, and medical equipment through physical stores and online platforms including Nahdi Online. It also operates the Nahdi Care polyclinic and provides virtual healthcare consultation services. The company was incorporated in 1986 and is headquartered in Jeddah.
TASIV estimates this company's intrinsic value using a DCF (Discounted Cash Flow) model. As of TASIV's most recent data refresh, the estimated intrinsic value is SAR 148.89 compared to a market price of SAR 91.65 (Trading significantly below DCF model value). This is an analytical estimate, not investment advice.
Revenue increased by about 17% over the three-year period, while net income moved in the opposite direction, declining by about 7%, indicating profitability weakened even as sales grew. Operating cash flow declined by a similar magnitude to revenue's increase, down by about 17%, diverging further from the revenue trend. Overall, the company's historical financial performance shows revenue growth alongside declines in both net income and operating cash flow.
Dividend per share rose every year over the 5-year recorded period, from SAR 2.31 to SAR 5.6, an increase of about 142%. Payments have been made on a Semi-Annual basis throughout this period. Overall, dividend per share has grown consistently across the recorded period. Current dividend yield is approximately 6.11%, with a payout ratio of approximately 87.63%.
TASIV's Competitive Advantage assessment for this company is High (75/100), based on profitability, predictability, financial strength, and growth resilience.
This company currently meets the following TASIV screener criteria: Value Screener.
Based on TASIV's DCF (Discounted Cash Flow) model, the estimated intrinsic value of Nahdi Medical Co. is approximately SAR 148.89, compared to a current market price of SAR 91.65. This is an analytical estimate based on the company's financial data, not investment advice or a recommendation to buy or sell.
According to TASIV's model, Nahdi Medical Co. is currently "Trading significantly below DCF model value".
Nahdi Medical Co.'s dividend yield is approximately 6.11%, with a payout ratio of approximately 87.63%, based on TASIV's most recent verified data.
Loading 4164...